PubRank

L K Newby

Author PubWeight™ 20.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem 1998 2.27
2 Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 2001 2.09
3 Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet 2004 1.94
4 Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart 2008 1.54
5 Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol 2001 1.51
6 Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect. J Clin Invest 1993 1.07
7 Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease. J Med Genet 2003 1.05
8 Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: have they been adequately evaluated? Am Heart J 1996 0.97
9 Cardiac markers: point of care testing. Clin Chim Acta 1999 0.87
10 Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. Am J Cardiol 2000 0.85
11 Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. JAMA 2000 0.83
12 How much do we gain by reducing time to reperfusion therapy? Am J Cardiol 1996 0.82
13 Troponins in pericarditis: implications for diagnosis and management of chest pains patients. Eur Heart J 2000 0.79
14 Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns. Heart 2005 0.78
15 Cardiac markers in the assessment of acute coronary syndromes. Md Med J 1997 0.78
16 Biochemical markers in suspected acute myocardial infarction: the need for early assessment. Clin Chem 1995 0.78
17 Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7. Circulation 1997 0.77
18 The emerging role of myoglobin for risk stratification. Am Heart J 2001 0.75
19 Oral glycoprotein IIb/IIIa antagonists: new insights from the SYMPHONY trial. J Thromb Thrombolysis 2000 0.75
20 The chest-pain unit--ready for prime time? N Engl J Med 1998 0.75
21 Cardiac marker testing: where should we focus? Am Heart J 2000 0.75
22 Post-traumatic pancreatitis. Gastrointest Endosc 1990 0.75
23 Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology 2004 0.75